nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—CYP2D6—Gefitinib—lung cancer	0.0725	0.32	CbGbCtD
Midodrine—CYP2D6—Vinorelbine—lung cancer	0.0559	0.246	CbGbCtD
Midodrine—CYP2D6—Erlotinib—lung cancer	0.0429	0.189	CbGbCtD
Midodrine—CYP2D6—Vinblastine—lung cancer	0.0344	0.152	CbGbCtD
Midodrine—CYP2D6—Doxorubicin—lung cancer	0.0212	0.0932	CbGbCtD
Midodrine—Melatonin—MT3—lung cancer	0.0149	0.865	CrCbGaD
Midodrine—Melatonin—CYP1A1—lung cancer	0.00232	0.135	CrCbGaD
Midodrine—Angiopathy—Paclitaxel—lung cancer	0.00108	0.00168	CcSEcCtD
Midodrine—Pain—Vinorelbine—lung cancer	0.00107	0.00167	CcSEcCtD
Midodrine—Hypertension—Gemcitabine—lung cancer	0.00107	0.00166	CcSEcCtD
Midodrine—Chills—Paclitaxel—lung cancer	0.00107	0.00166	CcSEcCtD
Midodrine—Hepatobiliary disease—Docetaxel—lung cancer	0.00106	0.00165	CcSEcCtD
Midodrine—Asthenia—Topotecan—lung cancer	0.00105	0.00164	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.00104	0.00163	CcSEcCtD
Midodrine—Confusional state—Irinotecan—lung cancer	0.00104	0.00162	CcSEcCtD
Midodrine—Asthenia—Erlotinib—lung cancer	0.00104	0.00162	CcSEcCtD
Midodrine—Mental disorder—Paclitaxel—lung cancer	0.00104	0.00162	CcSEcCtD
Midodrine—Hepatic function abnormal—Doxorubicin—lung cancer	0.00104	0.00162	CcSEcCtD
Midodrine—Pruritus—Topotecan—lung cancer	0.00104	0.00162	CcSEcCtD
Midodrine—Feeling abnormal—Vinorelbine—lung cancer	0.00103	0.00161	CcSEcCtD
Midodrine—Pruritus—Erlotinib—lung cancer	0.00103	0.0016	CcSEcCtD
Midodrine—Gastrointestinal pain—Vinorelbine—lung cancer	0.00103	0.0016	CcSEcCtD
Midodrine—Back pain—Etoposide—lung cancer	0.00102	0.00159	CcSEcCtD
Midodrine—Flatulence—Paclitaxel—lung cancer	0.00102	0.00159	CcSEcCtD
Midodrine—Nervous system disorder—Irinotecan—lung cancer	0.00101	0.00158	CcSEcCtD
Midodrine—Tension—Paclitaxel—lung cancer	0.00101	0.00158	CcSEcCtD
Midodrine—Muscle spasms—Etoposide—lung cancer	0.00101	0.00158	CcSEcCtD
Midodrine—Nervousness—Paclitaxel—lung cancer	0.001	0.00156	CcSEcCtD
Midodrine—Irritability—Methotrexate—lung cancer	0.001	0.00156	CcSEcCtD
Midodrine—Back pain—Paclitaxel—lung cancer	0.001	0.00156	CcSEcCtD
Midodrine—Dizziness—Vinblastine—lung cancer	0.000998	0.00155	CcSEcCtD
Midodrine—Urinary tract disorder—Docetaxel—lung cancer	0.000994	0.00155	CcSEcCtD
Midodrine—Muscle spasms—Paclitaxel—lung cancer	0.000994	0.00155	CcSEcCtD
Midodrine—Abdominal pain—Vinorelbine—lung cancer	0.000991	0.00154	CcSEcCtD
Midodrine—Nervous system disorder—Gemcitabine—lung cancer	0.000988	0.00154	CcSEcCtD
Midodrine—Urethral disorder—Docetaxel—lung cancer	0.000986	0.00154	CcSEcCtD
Midodrine—Skin disorder—Gemcitabine—lung cancer	0.000979	0.00152	CcSEcCtD
Midodrine—Anxiety—Cisplatin—lung cancer	0.000976	0.00152	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000973	0.00152	CcSEcCtD
Midodrine—Dizziness—Topotecan—lung cancer	0.000969	0.00151	CcSEcCtD
Midodrine—Dizziness—Erlotinib—lung cancer	0.000959	0.00149	CcSEcCtD
Midodrine—Erythema multiforme—Docetaxel—lung cancer	0.000951	0.00148	CcSEcCtD
Midodrine—Agitation—Paclitaxel—lung cancer	0.00095	0.00148	CcSEcCtD
Midodrine—Headache—Vinblastine—lung cancer	0.000945	0.00147	CcSEcCtD
Midodrine—Insomnia—Irinotecan—lung cancer	0.000935	0.00146	CcSEcCtD
Midodrine—Cardiac disorder—Docetaxel—lung cancer	0.000934	0.00146	CcSEcCtD
Midodrine—Flushing—Docetaxel—lung cancer	0.000934	0.00146	CcSEcCtD
Midodrine—Paraesthesia—Irinotecan—lung cancer	0.000929	0.00145	CcSEcCtD
Midodrine—Rash—Topotecan—lung cancer	0.000924	0.00144	CcSEcCtD
Midodrine—Dermatitis—Topotecan—lung cancer	0.000923	0.00144	CcSEcCtD
Midodrine—Dyspnoea—Irinotecan—lung cancer	0.000922	0.00144	CcSEcCtD
Midodrine—Nervous system disorder—Cisplatin—lung cancer	0.000921	0.00143	CcSEcCtD
Midodrine—Somnolence—Irinotecan—lung cancer	0.000919	0.00143	CcSEcCtD
Midodrine—Headache—Topotecan—lung cancer	0.000918	0.00143	CcSEcCtD
Midodrine—Tachycardia—Cisplatin—lung cancer	0.000916	0.00143	CcSEcCtD
Midodrine—Rash—Erlotinib—lung cancer	0.000914	0.00142	CcSEcCtD
Midodrine—Dermatitis—Erlotinib—lung cancer	0.000914	0.00142	CcSEcCtD
Midodrine—Angiopathy—Docetaxel—lung cancer	0.000913	0.00142	CcSEcCtD
Midodrine—Skin disorder—Cisplatin—lung cancer	0.000912	0.00142	CcSEcCtD
Midodrine—Insomnia—Gemcitabine—lung cancer	0.000911	0.00142	CcSEcCtD
Midodrine—Dyspepsia—Irinotecan—lung cancer	0.00091	0.00142	CcSEcCtD
Midodrine—Hypertension—Etoposide—lung cancer	0.00091	0.00142	CcSEcCtD
Midodrine—Headache—Erlotinib—lung cancer	0.000909	0.00142	CcSEcCtD
Midodrine—Paraesthesia—Gemcitabine—lung cancer	0.000905	0.00141	CcSEcCtD
Midodrine—Chills—Docetaxel—lung cancer	0.000903	0.00141	CcSEcCtD
Midodrine—Asthenia—Vinorelbine—lung cancer	0.0009	0.0014	CcSEcCtD
Midodrine—Dyspnoea—Gemcitabine—lung cancer	0.000898	0.0014	CcSEcCtD
Midodrine—Nausea—Vinblastine—lung cancer	0.000896	0.0014	CcSEcCtD
Midodrine—Somnolence—Gemcitabine—lung cancer	0.000896	0.0014	CcSEcCtD
Midodrine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000893	0.00139	CcSEcCtD
Midodrine—Hypertension—Paclitaxel—lung cancer	0.000892	0.00139	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000891	0.00139	CcSEcCtD
Midodrine—Pruritus—Vinorelbine—lung cancer	0.000887	0.00138	CcSEcCtD
Midodrine—Pain—Irinotecan—lung cancer	0.000884	0.00138	CcSEcCtD
Midodrine—Mental disorder—Docetaxel—lung cancer	0.000882	0.00137	CcSEcCtD
Midodrine—Anxiety—Paclitaxel—lung cancer	0.000877	0.00137	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000874	0.00136	CcSEcCtD
Midodrine—Nausea—Topotecan—lung cancer	0.000871	0.00136	CcSEcCtD
Midodrine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.00087	0.00136	CcSEcCtD
Midodrine—Abdominal discomfort—Methotrexate—lung cancer	0.000869	0.00135	CcSEcCtD
Midodrine—Confusional state—Etoposide—lung cancer	0.000867	0.00135	CcSEcCtD
Midodrine—Pain—Gemcitabine—lung cancer	0.000861	0.00134	CcSEcCtD
Midodrine—Nausea—Erlotinib—lung cancer	0.000861	0.00134	CcSEcCtD
Midodrine—Dry mouth—Paclitaxel—lung cancer	0.00086	0.00134	CcSEcCtD
Midodrine—Feeling abnormal—Irinotecan—lung cancer	0.000852	0.00133	CcSEcCtD
Midodrine—Confusional state—Paclitaxel—lung cancer	0.00085	0.00133	CcSEcCtD
Midodrine—Back pain—Docetaxel—lung cancer	0.000847	0.00132	CcSEcCtD
Midodrine—Dysuria—Methotrexate—lung cancer	0.000847	0.00132	CcSEcCtD
Midodrine—Gastrointestinal pain—Irinotecan—lung cancer	0.000846	0.00132	CcSEcCtD
Midodrine—Paraesthesia—Cisplatin—lung cancer	0.000843	0.00131	CcSEcCtD
Midodrine—Muscle spasms—Docetaxel—lung cancer	0.000842	0.00131	CcSEcCtD
Midodrine—Tachycardia—Etoposide—lung cancer	0.00084	0.00131	CcSEcCtD
Midodrine—Dyspnoea—Cisplatin—lung cancer	0.000837	0.0013	CcSEcCtD
Midodrine—Skin disorder—Etoposide—lung cancer	0.000836	0.0013	CcSEcCtD
Midodrine—Dry skin—Doxorubicin—lung cancer	0.000832	0.0013	CcSEcCtD
Midodrine—Feeling abnormal—Gemcitabine—lung cancer	0.00083	0.00129	CcSEcCtD
Midodrine—Dizziness—Vinorelbine—lung cancer	0.000829	0.00129	CcSEcCtD
Midodrine—Nervous system disorder—Paclitaxel—lung cancer	0.000827	0.00129	CcSEcCtD
Midodrine—Tachycardia—Paclitaxel—lung cancer	0.000823	0.00128	CcSEcCtD
Midodrine—Skin disorder—Paclitaxel—lung cancer	0.000819	0.00128	CcSEcCtD
Midodrine—Abdominal pain—Irinotecan—lung cancer	0.000818	0.00127	CcSEcCtD
Midodrine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000811	0.00126	CcSEcCtD
Midodrine—Pain—Cisplatin—lung cancer	0.000803	0.00125	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000801	0.00125	CcSEcCtD
Midodrine—Rash—Vinorelbine—lung cancer	0.000791	0.00123	CcSEcCtD
Midodrine—Dermatitis—Vinorelbine—lung cancer	0.00079	0.00123	CcSEcCtD
Midodrine—Stomatitis—Methotrexate—lung cancer	0.000787	0.00123	CcSEcCtD
Midodrine—Headache—Vinorelbine—lung cancer	0.000786	0.00122	CcSEcCtD
Midodrine—Feeling abnormal—Cisplatin—lung cancer	0.000774	0.00121	CcSEcCtD
Midodrine—Paraesthesia—Etoposide—lung cancer	0.000772	0.0012	CcSEcCtD
Midodrine—Dyspnoea—Etoposide—lung cancer	0.000767	0.0012	CcSEcCtD
Midodrine—Somnolence—Etoposide—lung cancer	0.000765	0.00119	CcSEcCtD
Midodrine—Hepatobiliary disease—Methotrexate—lung cancer	0.000764	0.00119	CcSEcCtD
Midodrine—Insomnia—Paclitaxel—lung cancer	0.000763	0.00119	CcSEcCtD
Midodrine—Paraesthesia—Paclitaxel—lung cancer	0.000757	0.00118	CcSEcCtD
Midodrine—Hypertension—Docetaxel—lung cancer	0.000756	0.00118	CcSEcCtD
Midodrine—Dyspnoea—Paclitaxel—lung cancer	0.000752	0.00117	CcSEcCtD
Midodrine—Somnolence—Paclitaxel—lung cancer	0.00075	0.00117	CcSEcCtD
Midodrine—Nausea—Vinorelbine—lung cancer	0.000745	0.00116	CcSEcCtD
Midodrine—Gastrointestinal disorder—Etoposide—lung cancer	0.000743	0.00116	CcSEcCtD
Midodrine—Dyspepsia—Paclitaxel—lung cancer	0.000742	0.00116	CcSEcCtD
Midodrine—Asthenia—Irinotecan—lung cancer	0.000742	0.00116	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000741	0.00115	CcSEcCtD
Midodrine—Pain—Etoposide—lung cancer	0.000736	0.00115	CcSEcCtD
Midodrine—Dysuria—Doxorubicin—lung cancer	0.000734	0.00114	CcSEcCtD
Midodrine—Dry mouth—Docetaxel—lung cancer	0.000729	0.00114	CcSEcCtD
Midodrine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000728	0.00113	CcSEcCtD
Midodrine—Pollakiuria—Doxorubicin—lung cancer	0.000725	0.00113	CcSEcCtD
Midodrine—Asthenia—Gemcitabine—lung cancer	0.000723	0.00113	CcSEcCtD
Midodrine—Pain—Paclitaxel—lung cancer	0.000721	0.00112	CcSEcCtD
Midodrine—Confusional state—Docetaxel—lung cancer	0.000721	0.00112	CcSEcCtD
Midodrine—Urinary tract disorder—Methotrexate—lung cancer	0.000716	0.00112	CcSEcCtD
Midodrine—Pruritus—Gemcitabine—lung cancer	0.000713	0.00111	CcSEcCtD
Midodrine—Urethral disorder—Methotrexate—lung cancer	0.000711	0.00111	CcSEcCtD
Midodrine—Feeling abnormal—Etoposide—lung cancer	0.000709	0.0011	CcSEcCtD
Midodrine—Gastrointestinal pain—Etoposide—lung cancer	0.000703	0.0011	CcSEcCtD
Midodrine—Nervous system disorder—Docetaxel—lung cancer	0.000701	0.00109	CcSEcCtD
Midodrine—Tachycardia—Docetaxel—lung cancer	0.000698	0.00109	CcSEcCtD
Midodrine—Feeling abnormal—Paclitaxel—lung cancer	0.000695	0.00108	CcSEcCtD
Midodrine—Skin disorder—Docetaxel—lung cancer	0.000694	0.00108	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000694	0.00108	CcSEcCtD
Midodrine—Gastrointestinal pain—Paclitaxel—lung cancer	0.00069	0.00107	CcSEcCtD
Midodrine—Erythema multiforme—Methotrexate—lung cancer	0.000686	0.00107	CcSEcCtD
Midodrine—Dizziness—Irinotecan—lung cancer	0.000684	0.00107	CcSEcCtD
Midodrine—Stomatitis—Doxorubicin—lung cancer	0.000682	0.00106	CcSEcCtD
Midodrine—Abdominal pain—Etoposide—lung cancer	0.00068	0.00106	CcSEcCtD
Midodrine—Asthenia—Cisplatin—lung cancer	0.000674	0.00105	CcSEcCtD
Midodrine—Cardiac disorder—Methotrexate—lung cancer	0.000673	0.00105	CcSEcCtD
Midodrine—Abdominal pain—Paclitaxel—lung cancer	0.000667	0.00104	CcSEcCtD
Midodrine—Hepatobiliary disease—Doxorubicin—lung cancer	0.000662	0.00103	CcSEcCtD
Midodrine—Angiopathy—Methotrexate—lung cancer	0.000658	0.00103	CcSEcCtD
Midodrine—Rash—Irinotecan—lung cancer	0.000652	0.00102	CcSEcCtD
Midodrine—Dermatitis—Irinotecan—lung cancer	0.000651	0.00102	CcSEcCtD
Midodrine—Chills—Methotrexate—lung cancer	0.000651	0.00101	CcSEcCtD
Midodrine—Headache—Irinotecan—lung cancer	0.000648	0.00101	CcSEcCtD
Midodrine—Insomnia—Docetaxel—lung cancer	0.000647	0.00101	CcSEcCtD
Midodrine—Paraesthesia—Docetaxel—lung cancer	0.000642	0.001	CcSEcCtD
Midodrine—Bradycardia—Doxorubicin—lung cancer	0.000639	0.000996	CcSEcCtD
Midodrine—Dyspnoea—Docetaxel—lung cancer	0.000637	0.000993	CcSEcCtD
Midodrine—Somnolence—Docetaxel—lung cancer	0.000636	0.00099	CcSEcCtD
Midodrine—Mental disorder—Methotrexate—lung cancer	0.000635	0.00099	CcSEcCtD
Midodrine—Rash—Gemcitabine—lung cancer	0.000635	0.00099	CcSEcCtD
Midodrine—Dermatitis—Gemcitabine—lung cancer	0.000635	0.000989	CcSEcCtD
Midodrine—Headache—Gemcitabine—lung cancer	0.000631	0.000983	CcSEcCtD
Midodrine—Dyspepsia—Docetaxel—lung cancer	0.000629	0.000981	CcSEcCtD
Midodrine—Urinary tract disorder—Doxorubicin—lung cancer	0.00062	0.000966	CcSEcCtD
Midodrine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000617	0.000962	CcSEcCtD
Midodrine—Asthenia—Etoposide—lung cancer	0.000617	0.000962	CcSEcCtD
Midodrine—Urethral disorder—Doxorubicin—lung cancer	0.000616	0.000959	CcSEcCtD
Midodrine—Nausea—Irinotecan—lung cancer	0.000614	0.000957	CcSEcCtD
Midodrine—Pain—Docetaxel—lung cancer	0.000611	0.000953	CcSEcCtD
Midodrine—Back pain—Methotrexate—lung cancer	0.000611	0.000952	CcSEcCtD
Midodrine—Pruritus—Etoposide—lung cancer	0.000609	0.000948	CcSEcCtD
Midodrine—Asthenia—Paclitaxel—lung cancer	0.000605	0.000943	CcSEcCtD
Midodrine—Nausea—Gemcitabine—lung cancer	0.000598	0.000932	CcSEcCtD
Midodrine—Pruritus—Paclitaxel—lung cancer	0.000597	0.00093	CcSEcCtD
Midodrine—Erythema multiforme—Doxorubicin—lung cancer	0.000594	0.000925	CcSEcCtD
Midodrine—Rash—Cisplatin—lung cancer	0.000592	0.000923	CcSEcCtD
Midodrine—Dermatitis—Cisplatin—lung cancer	0.000591	0.000922	CcSEcCtD
Midodrine—Feeling abnormal—Docetaxel—lung cancer	0.000589	0.000918	CcSEcCtD
Midodrine—Gastrointestinal pain—Docetaxel—lung cancer	0.000585	0.000911	CcSEcCtD
Midodrine—Cardiac disorder—Doxorubicin—lung cancer	0.000583	0.000908	CcSEcCtD
Midodrine—Flushing—Doxorubicin—lung cancer	0.000583	0.000908	CcSEcCtD
Midodrine—Angiopathy—Doxorubicin—lung cancer	0.00057	0.000888	CcSEcCtD
Midodrine—Dizziness—Etoposide—lung cancer	0.000569	0.000886	CcSEcCtD
Midodrine—Abdominal pain—Docetaxel—lung cancer	0.000565	0.000881	CcSEcCtD
Midodrine—Chills—Doxorubicin—lung cancer	0.000563	0.000878	CcSEcCtD
Midodrine—Dizziness—Paclitaxel—lung cancer	0.000558	0.000869	CcSEcCtD
Midodrine—Nausea—Cisplatin—lung cancer	0.000558	0.000869	CcSEcCtD
Midodrine—Mental disorder—Doxorubicin—lung cancer	0.00055	0.000857	CcSEcCtD
Midodrine—Rash—Etoposide—lung cancer	0.000542	0.000845	CcSEcCtD
Midodrine—Dermatitis—Etoposide—lung cancer	0.000542	0.000844	CcSEcCtD
Midodrine—Headache—Etoposide—lung cancer	0.000539	0.00084	CcSEcCtD
Midodrine—Flatulence—Doxorubicin—lung cancer	0.000539	0.000839	CcSEcCtD
Midodrine—Tension—Doxorubicin—lung cancer	0.000536	0.000836	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000534	0.000832	CcSEcCtD
Midodrine—Rash—Paclitaxel—lung cancer	0.000532	0.000829	CcSEcCtD
Midodrine—Dermatitis—Paclitaxel—lung cancer	0.000531	0.000828	CcSEcCtD
Midodrine—Nervousness—Doxorubicin—lung cancer	0.000531	0.000827	CcSEcCtD
Midodrine—Back pain—Doxorubicin—lung cancer	0.000529	0.000824	CcSEcCtD
Midodrine—Headache—Paclitaxel—lung cancer	0.000528	0.000823	CcSEcCtD
Midodrine—Muscle spasms—Doxorubicin—lung cancer	0.000526	0.000819	CcSEcCtD
Midodrine—Confusional state—Methotrexate—lung cancer	0.00052	0.00081	CcSEcCtD
Midodrine—Asthenia—Docetaxel—lung cancer	0.000513	0.000799	CcSEcCtD
Midodrine—Nausea—Etoposide—lung cancer	0.000511	0.000796	CcSEcCtD
Midodrine—Pruritus—Docetaxel—lung cancer	0.000506	0.000788	CcSEcCtD
Midodrine—Nervous system disorder—Methotrexate—lung cancer	0.000505	0.000787	CcSEcCtD
Midodrine—Agitation—Doxorubicin—lung cancer	0.000502	0.000783	CcSEcCtD
Midodrine—Nausea—Paclitaxel—lung cancer	0.000501	0.000781	CcSEcCtD
Midodrine—Skin disorder—Methotrexate—lung cancer	0.0005	0.00078	CcSEcCtD
Midodrine—Dizziness—Docetaxel—lung cancer	0.000473	0.000737	CcSEcCtD
Midodrine—Hypertension—Doxorubicin—lung cancer	0.000472	0.000735	CcSEcCtD
Midodrine—Insomnia—Methotrexate—lung cancer	0.000466	0.000726	CcSEcCtD
Midodrine—Anxiety—Doxorubicin—lung cancer	0.000464	0.000723	CcSEcCtD
Midodrine—Paraesthesia—Methotrexate—lung cancer	0.000463	0.000721	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000462	0.00072	CcSEcCtD
Midodrine—Dyspnoea—Methotrexate—lung cancer	0.000459	0.000716	CcSEcCtD
Midodrine—Somnolence—Methotrexate—lung cancer	0.000458	0.000714	CcSEcCtD
Midodrine—Dry mouth—Doxorubicin—lung cancer	0.000455	0.000709	CcSEcCtD
Midodrine—Dyspepsia—Methotrexate—lung cancer	0.000454	0.000707	CcSEcCtD
Midodrine—Rash—Docetaxel—lung cancer	0.000451	0.000702	CcSEcCtD
Midodrine—Dermatitis—Docetaxel—lung cancer	0.00045	0.000702	CcSEcCtD
Midodrine—Confusional state—Doxorubicin—lung cancer	0.00045	0.000701	CcSEcCtD
Midodrine—Headache—Docetaxel—lung cancer	0.000448	0.000698	CcSEcCtD
Midodrine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000445	0.000693	CcSEcCtD
Midodrine—Pain—Methotrexate—lung cancer	0.000441	0.000687	CcSEcCtD
Midodrine—Nervous system disorder—Doxorubicin—lung cancer	0.000438	0.000682	CcSEcCtD
Midodrine—Tachycardia—Doxorubicin—lung cancer	0.000435	0.000679	CcSEcCtD
Midodrine—Skin disorder—Doxorubicin—lung cancer	0.000433	0.000675	CcSEcCtD
Midodrine—Nausea—Docetaxel—lung cancer	0.000425	0.000662	CcSEcCtD
Midodrine—Feeling abnormal—Methotrexate—lung cancer	0.000425	0.000662	CcSEcCtD
Midodrine—Gastrointestinal pain—Methotrexate—lung cancer	0.000421	0.000657	CcSEcCtD
Midodrine—Abdominal pain—Methotrexate—lung cancer	0.000407	0.000635	CcSEcCtD
Midodrine—Insomnia—Doxorubicin—lung cancer	0.000404	0.000629	CcSEcCtD
Midodrine—Paraesthesia—Doxorubicin—lung cancer	0.000401	0.000624	CcSEcCtD
Midodrine—Dyspnoea—Doxorubicin—lung cancer	0.000398	0.00062	CcSEcCtD
Midodrine—Somnolence—Doxorubicin—lung cancer	0.000397	0.000618	CcSEcCtD
Midodrine—Dyspepsia—Doxorubicin—lung cancer	0.000393	0.000612	CcSEcCtD
Midodrine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000385	0.0006	CcSEcCtD
Midodrine—Pain—Doxorubicin—lung cancer	0.000382	0.000595	CcSEcCtD
Midodrine—Asthenia—Methotrexate—lung cancer	0.00037	0.000576	CcSEcCtD
Midodrine—Feeling abnormal—Doxorubicin—lung cancer	0.000368	0.000573	CcSEcCtD
Midodrine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000365	0.000569	CcSEcCtD
Midodrine—Pruritus—Methotrexate—lung cancer	0.000365	0.000568	CcSEcCtD
Midodrine—Abdominal pain—Doxorubicin—lung cancer	0.000353	0.00055	CcSEcCtD
Midodrine—Dizziness—Methotrexate—lung cancer	0.000341	0.000531	CcSEcCtD
Midodrine—Rash—Methotrexate—lung cancer	0.000325	0.000506	CcSEcCtD
Midodrine—Dermatitis—Methotrexate—lung cancer	0.000325	0.000506	CcSEcCtD
Midodrine—Headache—Methotrexate—lung cancer	0.000323	0.000503	CcSEcCtD
Midodrine—Asthenia—Doxorubicin—lung cancer	0.00032	0.000499	CcSEcCtD
Midodrine—Pruritus—Doxorubicin—lung cancer	0.000316	0.000492	CcSEcCtD
Midodrine—Nausea—Methotrexate—lung cancer	0.000306	0.000477	CcSEcCtD
Midodrine—Dizziness—Doxorubicin—lung cancer	0.000295	0.00046	CcSEcCtD
Midodrine—Rash—Doxorubicin—lung cancer	0.000281	0.000438	CcSEcCtD
Midodrine—Dermatitis—Doxorubicin—lung cancer	0.000281	0.000438	CcSEcCtD
Midodrine—Headache—Doxorubicin—lung cancer	0.00028	0.000436	CcSEcCtD
Midodrine—Nausea—Doxorubicin—lung cancer	0.000265	0.000413	CcSEcCtD
Midodrine—ADRA1B—Signaling Pathways—JUNB—lung cancer	4.43e-05	0.000388	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AVP—lung cancer	4.38e-05	0.000384	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ANXA1—lung cancer	4.38e-05	0.000384	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PIK3CB—lung cancer	4.37e-05	0.000383	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKR1C1—lung cancer	4.31e-05	0.000378	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3CG—lung cancer	4.3e-05	0.000377	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FLT1—lung cancer	4.24e-05	0.000372	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF1R—lung cancer	4.22e-05	0.00037	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3CG—lung cancer	4.2e-05	0.000368	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CXCL8—lung cancer	4.2e-05	0.000368	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—UGT1A1—lung cancer	4.19e-05	0.000367	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PIK3CD—lung cancer	4.16e-05	0.000365	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APP—lung cancer	4.15e-05	0.000364	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NOTCH3—lung cancer	4.15e-05	0.000364	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HES1—lung cancer	4.14e-05	0.000363	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGF9—lung cancer	4.12e-05	0.000361	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—POMC—lung cancer	4.09e-05	0.000358	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—RAF1—lung cancer	4.06e-05	0.000356	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GNG11—lung cancer	4.04e-05	0.000354	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—STK11—lung cancer	4.02e-05	0.000352	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—IL2—lung cancer	4.01e-05	0.000352	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—POMC—lung cancer	4e-05	0.000351	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6R—lung cancer	3.99e-05	0.00035	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PIK3CB—lung cancer	3.97e-05	0.000348	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—JUNB—lung cancer	3.93e-05	0.000345	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FOXO3—lung cancer	3.88e-05	0.00034	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALDOA—lung cancer	3.84e-05	0.000337	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3CG—lung cancer	3.82e-05	0.000334	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCL8—lung cancer	3.81e-05	0.000334	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—MAP2K1—lung cancer	3.8e-05	0.000333	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ERBB3—lung cancer	3.79e-05	0.000332	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3CD—lung cancer	3.78e-05	0.000331	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NCOA3—lung cancer	3.73e-05	0.000327	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3CD—lung cancer	3.7e-05	0.000324	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL2—lung cancer	3.64e-05	0.000319	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AVP—lung cancer	3.64e-05	0.000319	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—POMC—lung cancer	3.63e-05	0.000318	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TERT—lung cancer	3.63e-05	0.000318	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ADCY1—lung cancer	3.63e-05	0.000318	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ABCG2—lung cancer	3.63e-05	0.000318	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PIK3CB—lung cancer	3.63e-05	0.000318	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—STK11—lung cancer	3.57e-05	0.000313	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HPGDS—lung cancer	3.56e-05	0.000312	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ENO2—lung cancer	3.56e-05	0.000312	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6R—lung cancer	3.54e-05	0.000311	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PPP2R1B—lung cancer	3.54e-05	0.00031	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FGFR1—lung cancer	3.53e-05	0.000309	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF1R—lung cancer	3.5e-05	0.000307	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCL8—lung cancer	3.48e-05	0.000305	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HIF1A—lung cancer	3.47e-05	0.000304	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTT1—lung cancer	3.45e-05	0.000302	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FOXO3—lung cancer	3.45e-05	0.000302	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HES1—lung cancer	3.44e-05	0.000301	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP2A6—lung cancer	3.41e-05	0.000299	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GCLC—lung cancer	3.41e-05	0.000299	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—MAP2K1—lung cancer	3.38e-05	0.000296	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—RAF1—lung cancer	3.37e-05	0.000296	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3CD—lung cancer	3.36e-05	0.000294	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOA1—lung cancer	3.35e-05	0.000294	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—IL2—lung cancer	3.33e-05	0.000292	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—KDR—lung cancer	3.32e-05	0.000291	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3CB—lung cancer	3.29e-05	0.000289	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ENO1—lung cancer	3.24e-05	0.000283	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AVP—lung cancer	3.23e-05	0.000283	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3CB—lung cancer	3.22e-05	0.000282	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCL8—lung cancer	3.16e-05	0.000277	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ERBB3—lung cancer	3.14e-05	0.000275	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF1R—lung cancer	3.11e-05	0.000272	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCL8—lung cancer	3.1e-05	0.000271	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APC—lung cancer	3.06e-05	0.000268	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—KIT—lung cancer	3.06e-05	0.000268	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3CG—lung cancer	3.06e-05	0.000268	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—NRAS—lung cancer	3.06e-05	0.000268	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HES1—lung cancer	3.05e-05	0.000268	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL2—lung cancer	3.02e-05	0.000265	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EGF—lung cancer	3.02e-05	0.000265	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TERT—lung cancer	3.01e-05	0.000264	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—RAF1—lung cancer	3e-05	0.000263	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—IL2—lung cancer	2.96e-05	0.000259	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—MAPK3—lung cancer	2.93e-05	0.000257	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGFR1—lung cancer	2.93e-05	0.000256	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3CB—lung cancer	2.93e-05	0.000256	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—POMC—lung cancer	2.91e-05	0.000255	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP2E1—lung cancer	2.9e-05	0.000254	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HIF1A—lung cancer	2.88e-05	0.000252	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—BRAF—lung cancer	2.88e-05	0.000252	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NQO1—lung cancer	2.87e-05	0.000251	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6R—lung cancer	2.84e-05	0.000249	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CREBBP—lung cancer	2.84e-05	0.000248	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCL8—lung cancer	2.81e-05	0.000246	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ERBB3—lung cancer	2.79e-05	0.000245	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—EGFR—lung cancer	2.79e-05	0.000244	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOA1—lung cancer	2.78e-05	0.000244	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—KDR—lung cancer	2.76e-05	0.000241	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAP2K1—lung cancer	2.71e-05	0.000237	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3CD—lung cancer	2.69e-05	0.000236	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL2—lung cancer	2.69e-05	0.000235	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TERT—lung cancer	2.68e-05	0.000235	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PIK3CA—lung cancer	2.66e-05	0.000233	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—KRAS—lung cancer	2.63e-05	0.000231	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGFR1—lung cancer	2.6e-05	0.000228	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—STK11—lung cancer	2.59e-05	0.000227	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HIF1A—lung cancer	2.56e-05	0.000224	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—KIT—lung cancer	2.54e-05	0.000222	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3CG—lung cancer	2.54e-05	0.000222	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APC—lung cancer	2.54e-05	0.000222	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—NRAS—lung cancer	2.54e-05	0.000222	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EGF—lung cancer	2.51e-05	0.00022	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOA1—lung cancer	2.47e-05	0.000216	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—KDR—lung cancer	2.45e-05	0.000214	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—MAPK3—lung cancer	2.43e-05	0.000213	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PIK3CA—lung cancer	2.42e-05	0.000212	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—POMC—lung cancer	2.42e-05	0.000212	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MDM2—lung cancer	2.41e-05	0.000211	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RAF1—lung cancer	2.4e-05	0.00021	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTP1—lung cancer	2.39e-05	0.00021	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—BRAF—lung cancer	2.39e-05	0.000209	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ERBB2—lung cancer	2.38e-05	0.000208	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6R—lung cancer	2.36e-05	0.000207	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CREBBP—lung cancer	2.35e-05	0.000206	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3CB—lung cancer	2.34e-05	0.000205	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MTOR—lung cancer	2.34e-05	0.000205	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CAT—lung cancer	2.33e-05	0.000204	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—EGFR—lung cancer	2.31e-05	0.000203	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ABCB1—lung cancer	2.27e-05	0.000198	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—KIT—lung cancer	2.26e-05	0.000198	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APC—lung cancer	2.26e-05	0.000198	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	2.26e-05	0.000198	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—NRAS—lung cancer	2.26e-05	0.000198	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCL8—lung cancer	2.25e-05	0.000197	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAP2K1—lung cancer	2.25e-05	0.000197	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HRAS—lung cancer	2.24e-05	0.000196	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3CD—lung cancer	2.23e-05	0.000196	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EGF—lung cancer	2.23e-05	0.000195	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TYMS—lung cancer	2.22e-05	0.000195	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PIK3CA—lung cancer	2.21e-05	0.000194	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTM1—lung cancer	2.2e-05	0.000193	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—KRAS—lung cancer	2.19e-05	0.000191	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—AKT1—lung cancer	2.18e-05	0.000191	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	2.16e-05	0.000189	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CASP3—lung cancer	2.16e-05	0.000189	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL2—lung cancer	2.15e-05	0.000189	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—POMC—lung cancer	2.15e-05	0.000188	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—lung cancer	2.14e-05	0.000188	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—BRAF—lung cancer	2.12e-05	0.000186	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCND1—lung cancer	2.1e-05	0.000184	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6R—lung cancer	2.09e-05	0.000183	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—JUN—lung cancer	2.09e-05	0.000183	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CREBBP—lung cancer	2.09e-05	0.000183	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP1A1—lung cancer	2.08e-05	0.000183	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ERCC2—lung cancer	2.07e-05	0.000181	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—EGFR—lung cancer	2.05e-05	0.00018	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP9—lung cancer	2.04e-05	0.000179	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CDKN1A—lung cancer	2.03e-05	0.000178	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PTEN—lung cancer	2.03e-05	0.000177	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PIK3CA—lung cancer	2.01e-05	0.000176	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MDM2—lung cancer	2e-05	0.000175	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	2e-05	0.000175	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RAF1—lung cancer	1.99e-05	0.000175	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	1.98e-05	0.000174	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—AKT1—lung cancer	1.98e-05	0.000173	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ERBB2—lung cancer	1.97e-05	0.000173	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	1.96e-05	0.000172	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MTOR—lung cancer	1.95e-05	0.00017	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	1.95e-05	0.00017	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—KRAS—lung cancer	1.94e-05	0.00017	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EP300—lung cancer	1.93e-05	0.000169	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SRC—lung cancer	1.88e-05	0.000165	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL8—lung cancer	1.87e-05	0.000164	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HRAS—lung cancer	1.86e-05	0.000163	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—VEGFA—lung cancer	1.83e-05	0.00016	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—STAT3—lung cancer	1.81e-05	0.000159	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NRAS—lung cancer	1.81e-05	0.000158	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	1.81e-05	0.000158	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CASP3—lung cancer	1.79e-05	0.000157	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOA1—lung cancer	1.79e-05	0.000157	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL2—lung cancer	1.79e-05	0.000157	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	1.78e-05	0.000156	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—lung cancer	1.78e-05	0.000156	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MDM2—lung cancer	1.78e-05	0.000156	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RAF1—lung cancer	1.77e-05	0.000155	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ERBB2—lung cancer	1.75e-05	0.000153	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCND1—lung cancer	1.74e-05	0.000153	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—JUN—lung cancer	1.74e-05	0.000152	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK3—lung cancer	1.73e-05	0.000152	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	1.73e-05	0.000151	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MTOR—lung cancer	1.73e-05	0.000151	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP9—lung cancer	1.69e-05	0.000148	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	1.68e-05	0.000148	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MYC—lung cancer	1.68e-05	0.000147	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PTEN—lung cancer	1.68e-05	0.000147	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	1.66e-05	0.000145	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	1.65e-05	0.000145	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EGFR—lung cancer	1.65e-05	0.000144	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—AKT1—lung cancer	1.64e-05	0.000144	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.63e-05	0.000143	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	1.6e-05	0.000141	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EP300—lung cancer	1.6e-05	0.00014	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CASP3—lung cancer	1.59e-05	0.000139	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL2—lung cancer	1.59e-05	0.000139	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—lung cancer	1.58e-05	0.000138	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SRC—lung cancer	1.56e-05	0.000137	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—KRAS—lung cancer	1.56e-05	0.000136	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—POMC—lung cancer	1.55e-05	0.000136	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCND1—lung cancer	1.55e-05	0.000136	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—JUN—lung cancer	1.54e-05	0.000135	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	1.52e-05	0.000133	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CREBBP—lung cancer	1.51e-05	0.000133	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—STAT3—lung cancer	1.5e-05	0.000132	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP9—lung cancer	1.5e-05	0.000132	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NRAS—lung cancer	1.5e-05	0.000131	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	1.5e-05	0.000131	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTEN—lung cancer	1.49e-05	0.000131	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	1.46e-05	0.000128	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	1.44e-05	0.000126	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3CD—lung cancer	1.44e-05	0.000126	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	1.43e-05	0.000125	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EP300—lung cancer	1.42e-05	0.000125	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALB—lung cancer	1.42e-05	0.000124	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MYC—lung cancer	1.4e-05	0.000122	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SRC—lung cancer	1.38e-05	0.000121	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TP53—lung cancer	1.38e-05	0.000121	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EGFR—lung cancer	1.37e-05	0.00012	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	1.35e-05	0.000118	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—STAT3—lung cancer	1.34e-05	0.000117	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NRAS—lung cancer	1.33e-05	0.000117	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HRAS—lung cancer	1.32e-05	0.000116	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.29e-05	0.000113	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.28e-05	0.000112	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—lung cancer	1.27e-05	0.000111	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.25e-05	0.00011	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MYC—lung cancer	1.24e-05	0.000109	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTGS2—lung cancer	1.24e-05	0.000109	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.21e-05	0.000106	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.19e-05	0.000104	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—AKT1—lung cancer	1.17e-05	0.000102	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TP53—lung cancer	1.15e-05	0.000101	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.15e-05	0.0001	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.1e-05	9.61e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PTEN—lung cancer	1.08e-05	9.47e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	1.05e-05	9.23e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—lung cancer	1.05e-05	9.2e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—EP300—lung cancer	1.03e-05	9.03e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TP53—lung cancer	1.02e-05	8.93e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HRAS—lung cancer	9.75e-06	8.54e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—AKT1—lung cancer	9.69e-06	8.49e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—lung cancer	9.33e-06	8.17e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—AKT1—lung cancer	8.61e-06	7.54e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PIK3CA—lung cancer	7.63e-06	6.68e-05	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—AKT1—lung cancer	6.23e-06	5.46e-05	CbGpPWpGaD
